Loading clinical trials...
Loading clinical trials...
The prevalence of type 2 diabetes is rising in the population for many years. It is now recognized that a period of glucose intolerance precedes the clinical symptoms appearance. This is due to a comb...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Tel-Aviv Sourasky Medical Center
NCT06513026 · Lactose Intolerance, Lactose Intolerant, and more
NCT07403604 · Hyperinsulinemia, Insulin Resistance, and more
NCT07112339 · Diabetes Mellitus, Type 2
NCT07286747 · Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
NCT00001987 · Diabetes Mellitus, Severe Insulin Resistance
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions